|
1
|
Hong GK, Payne SC and Jane JA Jr: Anatomy,
physiology, and laboratory evaluation of the pituitary gland.
Otolaryngol Clin North Am. 49:21–32. 2016. View Article : Google Scholar
|
|
2
|
Amar AP and Weiss MH: Pituitary anatomy
and physiology. Neurosurg Clin N Am. 14:11–23. v2003. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Blackwell RE, Rodgers-Neame NT, Bradley EL
Jr and Asch RH: Regulation of human prolactin secretion by
gonadotropin-releasing hormone in vitro. Fertil Steril. 46:26–31.
1986. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Freeman ME, Kanyicska B, Lerant A and Nagy
G: Prolactin: Structure, function, and regulation of secretion.
Physiol Rev. 80:1523–1631. 2000.PubMed/NCBI
|
|
5
|
Ben-Jonathan N and Hnasko R: Dopamine as a
prolactin (PRL) inhibitor. Endocr Rev. 22:724–763. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Rillema JA: Mechanism of prolactin action.
Fed Proc. 39:2593–2598. 1980.PubMed/NCBI
|
|
7
|
McMurray RW: Estrogen, prolactin, and
autoimmunity: Actions and interactions. Int Immunopharmacol.
1:995–1008. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Capozzi A, Scambia G, Pontecorvi A and
Lello S: Hyperprolactinemia: Pathophysiology and therapeutic
approach. Gynecol Endocrinol. 31:506–510. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Glezer A and Bronstein MD: Prolactinomas.
Endocrinol Metab Clin North Am. 44:71–78. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Panossian A and Wikman G: Pharmacology of
Schisandra chinensis Bail: An overview of Russian research and uses
in medicine. J Ethnopharmacol. 118:183–212. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Hancke JL, Burgos RA and Ahumada F:
Schisandra chinensis (Turcz) Baill. Fitoterapia. 70:451–471. 1999.
View Article : Google Scholar
|
|
12
|
Chang HM and But P: Pharmacology and
applications of Chinese Materia Edica Volume 1. World Scientific;
Singapore: pp. 199–209. 1986, View Article : Google Scholar
|
|
13
|
Bao T-T, Tu G-F, Liu G-T, Sun R-H and Song
Z-Y: A comparison of the pharmacological actions of seven
constituents isolated from fructus schizadrae (author's transl).
Yao Xue Xue Bao. 14:1–7. 1979.In Chinese.
|
|
14
|
Cowie AT: Physiological actions of
prolactin. Proc R Soc Med. 66:861–862. 1973.PubMed/NCBI
|
|
15
|
Mancini T, Casanueva FF and Giustina A:
Hyperprolactinemia and prolactinomas. Endocrinol Metab Clin North
Am. 37:67–99. viii2008. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Schwärzler P, Untergasser G, Hermann M,
Dirnhofer S, Abendstein B and Berger P: Prolactin gene expression
and prolactin protein in premenopausal and postmenopausal human
ovaries. Fertil Steril. 68:696–701. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Ufearo CS and Orisakwe OE: Restoration of
normal sperm characteristics in hypoprolactinemic infertile men
treated with metoclopramide and exogenous human prolactin. Clin
Pharmacol Ther. 58:354–359. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Bronstein MD: Potential for long-term
remission of microprolactinoma after withdrawal of dopamine-agonist
therapy. Nat Clin Pract Endocrinol Metab. 2:130–131. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Auriemma RS, Pivonello R, Ferreri L,
Priscitelli P and Colao A: Cabergoline use for pituitary tumors and
valvular disorders. Endocrinol Metab Clin North Am. 44:89–97. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Murphy LL and Lee TJ: Ginseng, sex
behavior, and nitric oxide. Ann N Y Acad Sci. 962:372–377. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Yeh KY, Pu HF, Kaphle K, Lin SF, Wu LS,
Lin JH and Tsai YF: Ginkgo biloba extract enhances male copulatory
behavior and reduces serum prolactin levels in rats. Horm Behav.
53:225–231. 2008. View Article : Google Scholar
|
|
22
|
Lu JC, Piazza TM and Schuler LA:
Proteasomes mediate prolactin-induced receptor down-regulation and
fragment generation in breast cancer cells. J Biol Chem.
280:33909–33916. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Zinger M, McFarland M and Ben-Jonathan N:
Prolactin expression and secretion by human breast glandular and
adipose tissue explants. J Clin Endocrinol Metab. 88:689–696. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Chen CL and Meites J: Effects of estrogen
and progesterone on serum and pituitary prolactin levels in
ovariectomized rats. Endocrinology. 86:503–505. 1970. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Kang EJ, Hong SH, Lee JE, Kim SC, Yang HS,
Yi PI, Lee SM and An BS: Pregnenolone sulfate regulates prolactin
production in the rat pituitary. J Endocrinol. 230:339–346. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Yim SY, Lee YJ, Lee YK, Jung SE, Kim JH,
Kim HJ, Son BG, Park YH, Lee YG, Choi YW, et al: Gomisin N isolated
from Schisandra chinensis significantly induces anti-proliferative
and pro-apoptotic effects in hepatic carcinoma. Mol Med Rep.
2:725–732. 2009.PubMed/NCBI
|
|
27
|
Kim JH, Choi YW, Park C, Jin CY, Lee YJ,
Park DJ, Kim SG, Kim GY, Choi IW, Hwang WD, et al: Apoptosis
induction of human leukemia U937 cells by gomisin N, a
dibenzocyclooctadiene lignan, isolated from Schizandra chinensis
Baill. Food Chem Toxicol. 48:807–813. 2010. View Article : Google Scholar
|
|
28
|
Casarin E, Dall'Acqua S, Smejkal K,
Slapetova T, Innocenti G and Carrara M: Molecular mechanisms of
antiproliferative effects induced by Schisandra-derived
dienzocyclooctadiene lignin ()-deoxychisandrin and (-)-gomisin N in
human tumor cell lines. Fitoterapia. 98:241–247. 2014. View Article : Google Scholar : PubMed/NCBI
|
